When a pseudocyst develops after pancreatitis, current practice is to wait six weeks, during which many will resolve spontaneously. For drainage, there is increasing interest in endoscopic techniques.
Pancreatic pseudocyst drainage by endoscopic sphincterotomy
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CASE HISTORY
A man aged 50 was admitted with acute pancreatitis. Ultrasound examination revealed no gallstones or duct dilatation but suggested polyps in the gallbladder. He improved with conservative management. Sixteen days after discharge he was readmitted with further abdominal pain and a raised serum amylase. On this admission a computed tomographic (CT) scan showed a 2 cm fluid collection in the lesser sac. Again the symptoms resolved with conservative treatment and he was discharged, but required readmission three days later. On this occasion the serum amylase was only slightly raised, and there were signs of generalized peritonitis. At laparotomy he was found to have a ruptured pseudocyst. Cholecystectomy was performed because the gallbladder wall was thickened and there was a suspicion of stones, and a drain was inserted into the cyst cavity. On the eighth postoperative day a sinogram revealed a residual 2 x 2 cm cavity. The drain was removed and he was discharged home symptom-free, but four days later he was again readmitted with severe abdominal pain. A CT scan showed an 8 x 8 cm unilocular pseudocyst, and endoscopic retrograde pancreatography revealed a normal duct communicating with the pseudocyst. A sphincterotomy was performed, since we reasoned that a reduction in pressure in the ductal system might allow the cyst to decompress; and immediately afterwards the patient's symptoms dramatically resolved. A subsequent CT scan indicated complete resolution of the pseudocyst and the patient has been painfree and well for 48 months since the sphincterotomy. COMMENT About half of all patients with moderately severe pancreatitis go on to pseudocyst formation1'2. In those cysts which do not resolve spontaneously the wall is sufficiently mature after six weeks to allow safe surgical internal drainage. In 55-69% of patients, pseudocysts communicate with the pancreatic duct3-5. When they do not, the best treatment may be endoscopic transmural or surgical drainage, which has a success rate of 90-98%3,6. With cyst-gastrostomy the complication rate is 18%, although it is lower for cystduodenostomy, and the mortality is 8-10%. For those pseudocysts that do communicate with the ductal system transpapillary drainage is less invasive, probably safer, and is a suitable treatment. Binmoeller performed the technique with stent drainage in 33 patients with communicating pseudocysts5; all patients had a sphincterotomy and 4 required a combined procedure with transmural drainage. 31 had complete resolution of the pseudocyst. Dohmoto reported 9 patients who all had 7F pigtail catheters inserted6. 2 required endoscopic retrograde pancreatic drainage and endoscopic cyst-gastrostomy. All patients reported a reduction in their symptoms and the stents were removed after 2-12 months. In this series 4 patients experienced pain during the dilatation, and all patients had a rise in serum amylase and urinary lipase 1-2 days after the procedure. Kozarek et al.8 reported a series of 18 patients undergoing transpapillary drainage, of whom only 3 required sphincterotomy to facilitate stent insertion. The stents were inserted over a guide wire through the duct into the pseudocyst and were left in situ for an average of 6 weeks (range 4-72 weeks). 5 patients had complications (4 pancreatitis and I pseudocyst infection necessitating stent removal). 7 subsequently required surgery for persisting fluid collections. Thus stents may predispose to complications and do not necessarily prevent recurrence. In a collected series of 1020 cases the recurrence rate was 1.5%6.
We suggest that all patients with pseudocysts being considered for surgical drainage should undergo endoscopic cholangiopancreatography. If the duct system communicates with the pseudocyst, sphincterotomy can be performed without insertion of a stent unless there is an underlying abnormality of the ductal system. Haemorrhagic complications of thrombolytic therapy are numerous and are increased by repeated administration1 2. The risk of intracerebral bleeding is well recognized, and pulmonary, splenic, lingual, myocardial, pericardial and facial haemorrhage have all been described. Four cases of acute compartment syndrome associated with thrombolytic agents have been reported previously3-5 but all after some form of local trauma or intervention to the affected limb.
A woman aged 66 was seen in the accident and emergency department with a two-hour history of severe central chest pain. She had previously been fit and well and was on no medications. Acute inferior myocardial infarction was diagnosed from the admission electrocardiogram (ECG) and she was given 150mg aspirin. Since there were no contraindications, thrombolysis was begun: streptokinase 1.5 million units was given over 60 minutes via an intravenous cannula in her right hand but the ECG changes did not resolve; therefore, one hour after the streptokinase infusion had finished, alteplase was given in an accelerated regimen (15 mg bolus then 150mg over 30 minutes then 35 mg over 60 minutes). There was still no improvement in the ECG, so percutaneous transluminal coronary artery angioplasty and stenting was then performed via the right common femoral artery. Heparin was administered during this period and after the procedure (5000 units intravenous bolus and then 1000 units intravenously per hour) and the patient was started on ticlopidine 250mg twice daily. At the end of stenting, ECG changes had completely resolved. Four hours after the end of thrombolytic treatment, the patient's left arm became painful and swollen. All pulses were present and sensation was normal. Two hours later she was in severe pain, and on examination by the plastic surgeons, the arm was tense and pulseless. Sensation was absent in the distribution of the ulnar and median nerves. Acute compartment syndrome was diagnosed and the patient was taken immediately to the operating theatre, twelve hours after the onset of her chest pain.
Decompressive fasciotomies were performed. The muscles within the deep and superficial flexor compartments were bulging and heavily bloodstained from diffuse bleeding, without obvious focal bleeding points or haematomas. The wound was washed out and covered with a negative pressure dressing. A carpal tunnel decompression was also performed. There were no anaesthetic complications and at the end of the operation all pulses were palpable. Postoperatively the symptoms and signs resolved completely. The wound was closed under local anaesthesia 5 days later and when seen three months after operation the patient had made a complete recovery. COMMENT Acute compartment syndrome occurs when a rise in pressure compromises blood flow through the compartment. The initial insult (e.g. bleeding, trauma or ischaemia) causes swelling and thus decreases venous blood flow and tissue perfusion. Cellular ischaemia follows and, if the compartment is not surgically decompressed, the tissues become necrotic.
Clinical diagnosis can be difficult7. The earliest feature is pain, which can be very severe. The signs include swelling, paraesthesia and pain on passive stretching of the contained muscles. Arterial pulses and normal capillary refill may persist until very late. Intracompartmental pressure monitors offer an objective test, a pressure of greater than 45 mmHg being diagnostic.
When in doubt it is wise to err on the side of caution and perform decompressive fasciotomies.
This case is notable for the fact that the syndrome developed without trauma, and illustrates the need to think of spontaneous bleeding anywhere in the body after thrombolytic therapy. It also raises a question about the management
